Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.260
-0.170 (-11.89%)
At close: Nov 17, 2025, 4:00 PM EST
1.260
0.00 (0.00%)
After-hours: Nov 17, 2025, 7:57 PM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $6.82 million as of November 17, 2025. Its market cap has increased by 4.53% in one year.
Market Cap
6.82M
Enterprise Value
8.00M
1-Year Change
4.53%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $6.82M, a decrease of -88.35%. That is a compound annual growth rate of -41.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 7.74M | -46.82% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
| Nov 5, 2021 | 58.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |